Implications for global variations of lunar hydration and mineralogical mapping of Mercury with the MERTIS spectrometer
In the study that introduced it, ipamorelin released GH with a potency matching earlier GHRPs but uniquely without raising cortisol or prolactin, even at 200 the effective dose[1]
I am not the only one who has articulated this thinking (3)
Your eligibility depends on which facility you approach: some defer all GLP-1 users for a set window after injection, while others may allow donation if metabolic and cardiovascular parameters are stable
Importantly, such interventions are often low cost, relatively safe, may have other health benefits, and could be combined with future therapies specifically targeting neurodegeneration
Our NAD+ Premium IV therapy kicks it up a notch with a higher dose for greater potential effects